Adding Relacorilant To Nab-paclitaxel Prolongs Survival Compared with a Weekly Taxane in Patients with Platinum-Resistant Epithelial Ovarian Cancer By Ogkologos - June 23, 2025 654 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ROSELLA study Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR Efficacy and Safety of Trastuzumab Deruxtecan in Exploratory Cohorts of Patients... November 23, 2022 Apple Season is Here! October 1, 2021 LGBTQ+ Voices: Listening to Sexual and Gender Minority People Affected by... May 1, 2024 Alex Trebek Thanks Fans In “Mind-Boggling” Cancer Update. May 31, 2019 Load more HOT NEWS Fertility Preservation Safe for Young Women with Breast Cancer Neoadjuvant Niraparib Demonstrates Promising Antitumour Activity and Safety in Patients with... Answers to Your Questions About Sunscreen Ingredients Opinion: ‘Beating cancer means beating it for everyone’
